Abstract CT054: Amivantamab in Wild-Type Advanced Non-Small Cell Lung Cancer after Disease Progression on Checkpoint Inhibition and Chemotherapy: Results from the Phase 1b CHRYSALIS Study
Cancer Research(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined